|
|
| Quarterly Results |
|
| Krebs Biochemicals & Industries Ltd | | Industry : Pharmaceuticals - Indian - Bulk Drugs | Chairman : R T Ravi | | Home : Indian Private | Book Value: -50.2613955 | | BSE Code : 524518 | Market Cap: 156.49 | | NSE Code : KREBSBIO | P / E : 0 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 12.98 | 14.89 | 10.58 | 11.46 | | Other Income | 0.03 | 0.17 | 0.04 | 0.19 | | Total Income | 13.01 | 15.06 | 10.62 | 11.65 | | Total Expenditure | 15.07 | 15.79 | 13.20 | 16.08 | | Operating Profit | -2.06 | -0.73 | -2.58 | -4.43 | | Interest | 1.19 | 1.13 | 1.10 | 1.03 | | Gross Profit | -3.25 | -1.86 | -3.68 | -5.46 | | Depreciation | 1.73 | 1.71 | 1.65 | 1.48 | | Tax | 0.00 | 0.00 | 0.00 | 0.00 | | Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | | Reported Profit After Tax | -4.98 | -3.57 | -5.33 | -6.94 |
|
|
|
|
|